State Street Corp Phathom Pharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 922,788 shares of PHAT stock, worth $8.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
922,788
Previous 785,249 17.52%
Holding current value
$8.39 Million
Previous $8.09 Million 106.28%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.25 - $19.5 $1.41 Million - $2.68 Million
137,539 Added 17.52%
922,788 $16.7 Million
Q2 2024

Aug 14, 2024
BUY
$8.97 - $12.05 $610,390 - $819,978
68,048 Added 9.49%
785,249 $8.09 Million
Q1 2024

May 15, 2024
BUY
$6.21 - $11.05 $182,350 - $324,472
29,364 Added 4.27%
717,201 $7.62 Million
Q4 2023

Feb 14, 2024
BUY
$6.99 - $10.71 $141,484 - $216,781
20,241 Added 3.03%
687,837 $6.28 Million
Q3 2023

Nov 14, 2023
BUY
$10.26 - $15.7 $1.41 Million - $2.16 Million
137,753 Added 26.0%
667,596 $6.92 Million
Q2 2023

Aug 14, 2023
BUY
$7.28 - $14.32 $481,208 - $946,552
66,100 Added 14.25%
529,843 $7.59 Million
Q1 2023

May 15, 2023
BUY
$6.19 - $12.36 $76,718 - $153,189
12,394 Added 2.75%
463,743 $3.31 Million
Q4 2022

Feb 14, 2023
BUY
$9.18 - $11.53 $53,739 - $67,496
5,854 Added 1.31%
451,349 $5.06 Million
Q3 2022

Nov 15, 2022
BUY
$6.46 - $12.11 $236,519 - $443,383
36,613 Added 8.95%
445,495 $4.94 Million
Q2 2022

Aug 15, 2022
BUY
$6.2 - $15.5 $271,795 - $679,489
43,838 Added 12.01%
408,882 $3.45 Million
Q1 2022

May 16, 2022
BUY
$11.55 - $20.06 $266,851 - $463,466
23,104 Added 6.76%
365,044 $4.97 Million
Q4 2021

Feb 14, 2022
SELL
$17.83 - $33.15 $228,651 - $425,115
-12,824 Reduced 3.61%
341,940 $6.73 Million
Q3 2021

Nov 15, 2021
BUY
$30.69 - $36.83 $443,808 - $532,598
14,461 Added 4.25%
354,764 $11.4 Million
Q2 2021

Aug 16, 2021
BUY
$32.66 - $39.87 $4.02 Million - $4.91 Million
123,105 Added 56.68%
340,303 $11.5 Million
Q1 2021

May 17, 2021
BUY
$33.86 - $48.68 $275,891 - $396,644
8,148 Added 3.9%
217,198 $8.16 Million
Q4 2020

Feb 16, 2021
SELL
$33.22 - $50.26 $174,637 - $264,216
-5,257 Reduced 2.45%
209,050 $6.95 Million
Q3 2020

Nov 10, 2020
BUY
$29.24 - $40.19 $43,860 - $60,285
1,500 Added 0.7%
214,307 $7.86 Million
Q2 2020

Aug 14, 2020
BUY
$25.06 - $54.6 $639,004 - $1.39 Million
25,499 Added 13.61%
212,807 $7 Million
Q1 2020

May 11, 2020
BUY
$24.65 - $42.83 $4.62 Million - $8.02 Million
187,308 New
187,308 $4.84 Million

Others Institutions Holding PHAT

# of Institutions
144
Shares Held
73.6M
Call Options Held
42.3K
Put Options Held
45.7K
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $356M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email